Laparoscopic pancreatic surgery in patients with neuroendocrine tumours:: indications and limits

被引:46
|
作者
Fernández-Cruz, L [1 ]
Herrera, M
Sáenz, A
Pantoja, JP
Astudillo, E
Sierra, M
机构
[1] Univ Barcelona, Hosp Clin, Inst Digest Dis IMD, Dept Surg,Gastrointestinal Surg Dept, Barcelona, Spain
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, INNSZ, Mexico City, DF, Mexico
关键词
endocrine pancreatic tumours; non-functioning tumour; insulinoma; laparoscopic distal pancreatectomy; laparoscopic enucleation; laparoscopic ultrasonography; laparoscopic spleen salvage;
D O I
10.1053/beem.2001.0133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laparoscopic pancreatic procedures are still at an evaluation stage with regard to their indications and techniques. Between January 1998 and December 2000, 13 patients with endocrine pancreatic tumours - 11 insulinomas and 2 non-functioning rumours - underwent laparoscopic surgery, laparoscopic ultrasonography being used in all the patients. Enucleation was performed in five patients. The operative time was 2-3 hours. Distal pancreatectomy was performed in six patients with insulinomas, and spleen preservation with intact splenic vessels was feasible in five. Splenectomy was necessary in one patient for technical reasons. Laparoscopic distal pancreatectomy with splenic vessel preservation was performed in two patients with a large (6 and 8 cm) non-functioning tumour. The mean operative time for all the patients undergoing distal pancreatectomy was 4 hours, ranging from 3 to 5 hours. A pancreatic fistula occurred in three patients after tumour enucleation and in two patients after distal pancreatectomy; the mean hospital stay for all patients was 5 days. Enucleation guided by laparoscopic ultrasonography thus allows safe tumour dissection and excision, laparoscopic distal pancreatectomy also being feasible and safe. Splenic salvage with splenic vessel preservation is technically possible. The laparoscopic approach allows a shorter hospital stay and an earlier return to normal activities.
引用
收藏
页码:161 / 175
页数:15
相关论文
共 50 条
  • [31] Advances in the treatment of pancreatic neuroendocrine tumours
    Gao, F.
    Visvardis, E. -E. P.
    Sita-Lumsden, A.
    Waxman, J.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (09) : 819 - 822
  • [32] Transcriptomic landscape of pancreatic neuroendocrine tumours
    Rogoza, Olesja
    Niedra, Helvijs
    Saksis, Rihards
    Gerina-Berzina, Aija
    Vilisova, Sofija
    Earl, Julie
    Caracuel, Ignacio Ruz
    Smolkova, Bozena
    Kolnikova, Georgina
    Dubovan, Peter
    Makovicky, Peter
    Koniaris, Eythimios
    Kataki, Agapi
    Rovite, Vita
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 379 - 379
  • [33] Long-Term Outcome of Laparoscopic Surgery for Pancreatic Neuroendocrine Tumors
    Sven-Petter Haugvik
    Irina Pavlik Marangos
    Bård Ingvald Røsok
    Ewa Pomianowska
    Ivar Prydz Gladhaug
    Øystein Mathisen
    Bjørn Edwin
    [J]. World Journal of Surgery, 2013, 37 : 582 - 590
  • [34] Duodeno-pancreatic neuroendocrine tumours
    Peros, G.
    Sakorafas, G. H.
    Konstantoudakis, G.
    Giannopoulos, G. A.
    Petropoulou, K.
    Parasi, A.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (03) : 393 - 402
  • [35] Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours
    Crona, Joakim
    Norlen, Olov
    Antonodimitrakis, Pantelis
    Welin, Staffan
    Stalberg, Peter
    Eriksson, Barbro
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (02): : 445 - 452
  • [36] Prognostic factors in resected pancreatic neuroendocrine tumours: Experience in 95 patients
    Sanchez-Bueno, Francisco
    Rodriguez Gonzalez, Jose Manuel
    Torres Salmeron, Gloria
    Bernabe Penalver, Antonio
    Balsalobre Salmeron, Maria
    de la Pena Moral, Jesus
    Fuster Quinonero, Matilde
    Parrilla Paricio, Pascual
    [J]. CIRUGIA ESPANOLA, 2016, 94 (08): : 473 - 480
  • [37] Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease
    Zwolak, Agnieszka
    Swirska, Joanna
    Tywanek, Ewa
    Dudzinska, Marta
    Tarach, Jerzy S.
    Matyjaszek-Matuszek, Beata
    [J]. ENDOKRYNOLOGIA POLSKA, 2020, 71 (03) : 256 - 259
  • [38] Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
    Megdanova-Chipeva, Vera G.
    Lamarca, Angela
    Backen, Alison
    McNamara, Mairead G.
    Barriuso, Jorge
    Sergieva, Sonia
    Gocheva, Lilia
    Mansoor, Was
    Manoharan, Prakash
    Valle, Juan W.
    [J]. CANCERS, 2020, 12 (07) : 1 - 29
  • [39] Understanding Treatment Algorithms in Patients with Metastatic Pancreatic Neuroendocrine Tumours (mPNET)
    Hayes, A. R.
    Mak, I. Y. F.
    Evans, N.
    Naik, R.
    Crawford, A.
    Khoo, B.
    Grossman, A. B.
    Mandair, D.
    Toumpanakis, C.
    Thirlwell, C.
    Caplin, M.
    Meyer, T.
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 181 - 181
  • [40] Epidemiological Factors at Diagnosis in a Large Cohort of Patients with Pancreatic Neuroendocrine Tumours
    Koffas, A.
    Demetriou, G.
    Gvozdanovic, A.
    Brooks, P. R.
    CJ, Horan
    Laskaratos, F. M.
    Garcia-Hernandez, J.
    Mullan, M.
    Papadopoulou, A.
    Grant, L.
    Mandair, D.
    Caplin, M.
    Toumpanakis, C.
    [J]. NEUROENDOCRINOLOGY, 2017, 105 : 109 - 109